GTS Securities’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $769K | Buy |
18,948
+641
| +4% | +$26K | 0.03% | 467 |
|
|
2025
Q1 | $802K | Buy |
+18,307
| New | +$802K | 0.03% | 474 |
|
|
2024
Q4 | – | Sell |
-25,284
| Closed | -$1.12M | – | 2242 |
|
|
2024
Q3 | $1.12M | Buy |
25,284
+18,308
| +262% | +$812K | ﹤0.01% | 619 |
|
|
2024
Q2 | $278K | Sell |
6,976
-24,898
| -78% | -$990K | ﹤0.01% | 1232 |
|
|
2024
Q1 | $1.37M | Buy |
31,874
+19,712
| +162% | +$850K | ﹤0.01% | 445 |
|
|
2023
Q4 | $506K | Buy |
+12,162
| New | +$506K | ﹤0.01% | 912 |
|